Nutex Health (NASDAQ:NUTX) Sets New 12-Month High – Should You Buy?

Shares of Nutex Health Inc. (NASDAQ:NUTX) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $201.49 and last traded at $193.9440, with a volume of 31238 shares. The stock had previously closed at $190.71.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Zacks Research raised Nutex Health to a “hold” rating in a report on Monday. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Lake Street Capital assumed coverage on Nutex Health in a research report on Tuesday, June 2nd. They set a “buy” rating and a $235.00 price target on the stock. B. Riley Financial began coverage on Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective for the company. Finally, Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Monday, May 4th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $243.33.

Nutex Health Price Performance

The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.12 and a current ratio of 3.14. The company has a market capitalization of $1.31 billion, a PE ratio of 14.76 and a beta of 0.21. The company’s 50-day simple moving average is $133.49 and its 200-day simple moving average is $129.94.

Nutex Health (NASDAQ:NUTX) last announced its earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, beating analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%. The business had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million. As a group, sell-side analysts anticipate that Nutex Health Inc. will post 22.72 earnings per share for the current year.

Institutional Trading of Nutex Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Bank of America Corp DE lifted its position in Nutex Health by 52.3% during the 1st quarter. Bank of America Corp DE now owns 9,027 shares of the company’s stock worth $858,000 after acquiring an additional 3,101 shares during the period. Smith Group Asset Management LLC purchased a new position in shares of Nutex Health in the 1st quarter valued at approximately $1,244,000. EverSource Wealth Advisors LLC acquired a new position in shares of Nutex Health in the first quarter valued at approximately $83,000. Empowered Funds LLC acquired a new position in shares of Nutex Health in the first quarter valued at approximately $3,084,000. Finally, Quantinno Capital Management LP purchased a new stake in shares of Nutex Health during the first quarter worth approximately $843,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.